Literature DB >> 30447922

A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectives.

Antonio Chiappa1, Bruno Andreoni2, Renzo Dionigi3, Lorenzo Spaggiari4, Diego Foschi5, Gianluca Polvani6, Roberto Orecchia7, Nicola Fazio8, Gabriella Pravettoni9, Maria Laura Cossu10, Domenico Galetta4, Marco Venturino11, Carlo Ferrari12, Lorenzo Macone12, Cristiano Crosta13, Bernardo Bonanni14, Roberto Biffi15.   

Abstract

Cancer of the esophagus and of gastroesophageal junction can be cured, even if with lacking cure rate. Different approaches have been developed, mostly when carcinoma has loco-regional pattern. Multimodality therapy showed a survival rate superior than 10% if compared to a single approach. This is a systematic review, carried to assess the following matters: Which therapeutic opportunities are available? Who could benefit of them? Which adverse reactions could possibly verify? How can physicians definitely choose the proper strategy? Which is the role of surgery? We mean to give either General Practitioner or specialists clear and efficient updates about current treatment of this tumour, starting from physical examination. Four eminent guidelines were consulted for our study: Cancer Care Ontario's Program in Evidence-Based Care, NCCN, Belgian Health Care Knowledge Centre and Esmo.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Esophageal Cancer; Gastroesophageal junction cancer; Multimodal therapy; Surgical oncology

Mesh:

Year:  2018        PMID: 30447922     DOI: 10.1016/j.critrevonc.2018.10.002

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  3 in total

1.  Clinicopathological Characteristics and Survival Predictions for Adenocarcinoma of the Esophagogastric Junction: A SEER Population-Based Retrospective Study.

Authors:  Xin Liu; Qingtao Jiang; Chao Yue; Qin Wang
Journal:  Int J Gen Med       Date:  2021-12-24

2.  Cardiovascular Burden and Adverse Events in Patients With Esophageal Cancer Treated With Chemoradiation for Curative Intent.

Authors:  Mette Marie A Søndergaard; Marianne Nordsmark; Kirsten M Nielsen; Steen H Poulsen
Journal:  JACC CardioOncol       Date:  2021-12-21

3.  Sequential treatment of severe airway stenosis caused by esophageal cancer by using airway stent implantation and arterial infusion chemotherapy.

Authors:  Pengfei Xie; Shuai Wang; Wei He; Meipan Yin; Chunxia Li; Zhen Li; Xiaobing Li; Yaozhen Ma; Guang Yang; Gang Wu
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.